Adeno-Associated Virus (AAV) Mediated Dystrophin Gene Transfer Studies and Exon Skipping Strategies for Duchenne Muscular Dystrophy (DMD)

By  

Current Gene Therapy, Vol. 15, Iss. 4, 2015-01 ,pp. : 395-415

Bentham Science Publishers

Access to resources Recommend Favorite

Restriction Factors Against Recombinant Adeno-associated Virus Vectormediated Gene Transfer in Dystrophin-deficient Muscles

By  

Current Gene Therapy, Vol. 16, Iss. 3, 2016-06 ,pp. : 168-183

Bentham Science Publishers

Access to resources Recommend Favorite

Adeno-associated virus structural biology as a tool in vector development

By Drouin Lauren M   Agbandje-McKenna Mavis  

Future Virology, Vol. 8, Iss. 12, 2013-12 ,pp. : 1183-1199

Future Medicine

Access to resources Recommend Favorite

Enhancement of expression of vascular endothelial growth factor after adeno-associated virus gene transfer is associated with improvement of brain ischemia injury in the gerbil

By Bellomo M.   Adamo E.B.   Deodato B.   Catania M.A.   Mannucci C.   Marini H.   Marciano M.C.   Marini R.   Sapienza S.   Giacca M.   Caputi A.P.   Squadrito F.   Calapai G.  

Pharmacological Research, Vol. 48, Iss. 3, 2003-09 ,pp. : 309-317

Elsevier

Access to resources Recommend Favorite

Safety of adeno-associated virus gene therapy vectors: a current evaluation

By Monahan Paul E   Jooss Karin   Sands Mark S  

Expert Opinion on Drug Safety, Vol. 1, Iss. 1, 2002-05 ,pp. : 79-91

Informa Healthcare

Access to resources Recommend Favorite